Cogent Biosciences, Inc. COGT Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s total costs & expenses?
- Cogent Biosciences, Inc. (COGT) reported total costs & expenses of $103.61M in Q1 2026.
- How has Cogent Biosciences, Inc.'s total costs & expenses changed year-over-year?
- Cogent Biosciences, Inc.'s total costs & expenses increased by 38.3% year-over-year, from $74.93M to $103.61M.
- What is the long-term trend for Cogent Biosciences, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s total costs & expenses has grown at a 44.9% compound annual growth rate (CAGR), from $75.55M to $333.36M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company during a reporting period. It encompasses research and development investments, general and administrative overhead, and other operational expenditures necessary to sustain business activities. Monitoring this total provides insight into the company's overall burn rate and operational scale.